Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)

Overview of attention for article published in Cardiovascular Diabetology, January 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#41 of 1,449)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 4 tweets from 4 users, with an upper bound of 30,053 followers.

以前の論文試験デザインについて書いてありますhttps://t.co/BMI4eAp7rI / #JJCLIP キャス https://t.co/OTAa7O1d38

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of 　 http://t.co/UvHHm1Gv3l

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity.